2
|
Molisani SE, Parikh D, DiGiovine M, Dlugos D, Fitzgerald MP, Fried L, Helbig I, Kessler SK, McDonnell PP, Melamed S, Prelack MS, Sharif U, Tefft S, Tencer J, Witzman S, Shaw K, Abend NS. A quality improvement initiative to improve folic acid supplementation counseling for adolescent females with epilepsy. Epilepsia 2023; 64:2818-2826. [PMID: 37496463 DOI: 10.1111/epi.17723] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2023] [Revised: 07/20/2023] [Accepted: 07/24/2023] [Indexed: 07/28/2023]
Abstract
OBJECTIVE We designed a quality improvement (QI) project to improve rates of documented folic acid supplementation counseling for adolescent females with epilepsy, consistent with a quality measure from the American Academy of Neurology and American Epilepsy Society. Our SMART aim was to increase the percentage of visits at which folic acid counseling was addressed from our baseline rate of 23% to 50% by July 1, 2020. METHODS This initiative was conducted in female patients ≥12 years old with epilepsy who were prescribed daily antiseizure medication and were seen by the 13 providers in our Neurology QI Program. Using provider interviews, we undertook a root cause analysis of low counseling rates and identified the following main factors: insufficient time during clinic visit to counsel, lack of provider knowledge, and forgetting to counsel. Countermeasures were designed to address these main root causes and were implemented through iterative plan-do-study-act (PDSA) cycles. Interventions included provider education and features within the electronic health record, which were introduced sequentially, culminating in the creation of a best practice advisory (BPA). We performed biweekly chart reviews of visits for applicable patients to establish baseline performance rate and track progress over time. We used a statistical process control p-chart to analyze the outcome measure of documented counseling. As a balancing measure, clinicians were surveyed using the Technology Adoption Model survey to assess acceptance of the BPA. RESULTS From September 2019 to August 2022, the QI team improved rates of documented folic acid counseling from 23% to 73% through several PDSA cycles. This level of performance has been sustained over time. The most successful and sustainable intervention was the BPA. Provider acceptance of the BPA was overall positive. SIGNIFICANCE We successfully used QI methodology to improve and sustain our rates of documented folic acid supplementation counseling for adolescent females with epilepsy.
Collapse
Affiliation(s)
- Sara E Molisani
- Department of Pediatrics (Division of Neurology), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
- Departments of Neurology and Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
| | - Darshana Parikh
- Department of Pediatrics (Division of Neurology), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
| | - Marissa DiGiovine
- Department of Pediatrics (Division of Neurology), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
- Departments of Neurology and Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
| | - Dennis Dlugos
- Department of Pediatrics (Division of Neurology), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
- Departments of Neurology and Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
| | - Mark P Fitzgerald
- Department of Pediatrics (Division of Neurology), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
- Departments of Neurology and Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
- Epilepsy Neurogenetics Initiative, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
- Epilepsy and Neurodevelopmental Disorders Center, University of Pennsylvania and Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
| | - Lawrence Fried
- Department of Pediatrics (Division of Neurology), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
- Departments of Neurology and Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
| | - Ingo Helbig
- Department of Pediatrics (Division of Neurology), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
- Departments of Neurology and Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
- Epilepsy Neurogenetics Initiative, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
- Epilepsy and Neurodevelopmental Disorders Center, University of Pennsylvania and Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
- Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
| | - Sudha Kilaru Kessler
- Department of Pediatrics (Division of Neurology), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
- Departments of Neurology and Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
| | - Pamela Pojomovsky McDonnell
- Department of Pediatrics (Division of Neurology), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
- Departments of Neurology and Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
- Epilepsy Neurogenetics Initiative, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
| | - Susan Melamed
- Department of Pediatrics (Division of Neurology), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
| | - Marisa S Prelack
- Department of Pediatrics (Division of Neurology), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
- Departments of Neurology and Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
| | - Uzma Sharif
- Department of Pediatrics (Division of Neurology), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
- Departments of Neurology and Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
| | - Sarah Tefft
- Department of Pediatrics (Division of Neurology), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
- Epilepsy Neurogenetics Initiative, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
- Epilepsy and Neurodevelopmental Disorders Center, University of Pennsylvania and Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
| | - Jaclyn Tencer
- Department of Pediatrics (Division of Neurology), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
| | - Stephanie Witzman
- Department of Pediatrics (Division of Neurology), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
| | - Kathy Shaw
- Department of Pediatrics (Division of Emergency Medicine), Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
| | - Nicholas S Abend
- Department of Pediatrics (Division of Neurology), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
- Departments of Neurology and Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
| |
Collapse
|
3
|
Lo CB, Conrad B, Debs A, Herbst J, Kulkarni N, Nelson DM, Wentzel E, Cohen DM, Patel AD. Counseling on the Need for Folic Acid in Adolescents With Epilepsy. Neurol Clin Pract 2023; 13:e200177. [PMID: 37529297 PMCID: PMC10389172 DOI: 10.1212/cpj.0000000000200177] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2022] [Accepted: 05/09/2023] [Indexed: 08/03/2023]
Abstract
Background and Objectives Folic acid is an important supplement to take for women with epilepsy on antiseizure medications (ASMs). Determination of baseline counseling given to women with epilepsy and the association with folic acid being recommended were evaluated. Factors surrounding the association were reviewed. Methods An exploratory retrospective review of women with epilepsy seen at a large Midwestern pediatric institution was performed between January 2018 and January 2020. Results Patients who received preconception counseling were more likely to be given a recommendation to take folic acid. Patients on more than 1 ASM were likely to receive counseling. Patient age and race were associated with having folic acid recommended. Discussion Providing preconception counseling for women with epilepsy is associated with an increased recommendation and prescription of folic acid. Further evaluation into possible disparities to receiving a folic acid recommendation is needed.
Collapse
Affiliation(s)
- Charmaine B Lo
- Division of Emergency Medicine (CBL, DMN, DMC), Nationwide Children's Hospital; Pediatric Emergency Medicine (CBL), Abigail Wexner Research Institute at Nationwide Children's Hospital; The Ohio State University College of Medicine (BC); Division of Neurology (AD, NK, EW, ADP), Nationwide Children's Hospital; Endocrinology and Metabolism Institute (AD), Cleveland Clinic; Department of Pharmacy (JH), Nationwide Children's Hospital, Columbus, OH; Lincoln Memorial University (DMN), Debusk College of Osteopathic Medicine, Knoxville, TN; Department of Pediatrics (DMC, ADP), The Ohio State University College of Medicine; and The Center for Clinical Excellence (ADP), Nationwide Children's Hospital, Columbus, OH
| | - Bailey Conrad
- Division of Emergency Medicine (CBL, DMN, DMC), Nationwide Children's Hospital; Pediatric Emergency Medicine (CBL), Abigail Wexner Research Institute at Nationwide Children's Hospital; The Ohio State University College of Medicine (BC); Division of Neurology (AD, NK, EW, ADP), Nationwide Children's Hospital; Endocrinology and Metabolism Institute (AD), Cleveland Clinic; Department of Pharmacy (JH), Nationwide Children's Hospital, Columbus, OH; Lincoln Memorial University (DMN), Debusk College of Osteopathic Medicine, Knoxville, TN; Department of Pediatrics (DMC, ADP), The Ohio State University College of Medicine; and The Center for Clinical Excellence (ADP), Nationwide Children's Hospital, Columbus, OH
| | - Andrea Debs
- Division of Emergency Medicine (CBL, DMN, DMC), Nationwide Children's Hospital; Pediatric Emergency Medicine (CBL), Abigail Wexner Research Institute at Nationwide Children's Hospital; The Ohio State University College of Medicine (BC); Division of Neurology (AD, NK, EW, ADP), Nationwide Children's Hospital; Endocrinology and Metabolism Institute (AD), Cleveland Clinic; Department of Pharmacy (JH), Nationwide Children's Hospital, Columbus, OH; Lincoln Memorial University (DMN), Debusk College of Osteopathic Medicine, Knoxville, TN; Department of Pediatrics (DMC, ADP), The Ohio State University College of Medicine; and The Center for Clinical Excellence (ADP), Nationwide Children's Hospital, Columbus, OH
| | - James Herbst
- Division of Emergency Medicine (CBL, DMN, DMC), Nationwide Children's Hospital; Pediatric Emergency Medicine (CBL), Abigail Wexner Research Institute at Nationwide Children's Hospital; The Ohio State University College of Medicine (BC); Division of Neurology (AD, NK, EW, ADP), Nationwide Children's Hospital; Endocrinology and Metabolism Institute (AD), Cleveland Clinic; Department of Pharmacy (JH), Nationwide Children's Hospital, Columbus, OH; Lincoln Memorial University (DMN), Debusk College of Osteopathic Medicine, Knoxville, TN; Department of Pediatrics (DMC, ADP), The Ohio State University College of Medicine; and The Center for Clinical Excellence (ADP), Nationwide Children's Hospital, Columbus, OH
| | - Neil Kulkarni
- Division of Emergency Medicine (CBL, DMN, DMC), Nationwide Children's Hospital; Pediatric Emergency Medicine (CBL), Abigail Wexner Research Institute at Nationwide Children's Hospital; The Ohio State University College of Medicine (BC); Division of Neurology (AD, NK, EW, ADP), Nationwide Children's Hospital; Endocrinology and Metabolism Institute (AD), Cleveland Clinic; Department of Pharmacy (JH), Nationwide Children's Hospital, Columbus, OH; Lincoln Memorial University (DMN), Debusk College of Osteopathic Medicine, Knoxville, TN; Department of Pediatrics (DMC, ADP), The Ohio State University College of Medicine; and The Center for Clinical Excellence (ADP), Nationwide Children's Hospital, Columbus, OH
| | - Dustin Mark Nelson
- Division of Emergency Medicine (CBL, DMN, DMC), Nationwide Children's Hospital; Pediatric Emergency Medicine (CBL), Abigail Wexner Research Institute at Nationwide Children's Hospital; The Ohio State University College of Medicine (BC); Division of Neurology (AD, NK, EW, ADP), Nationwide Children's Hospital; Endocrinology and Metabolism Institute (AD), Cleveland Clinic; Department of Pharmacy (JH), Nationwide Children's Hospital, Columbus, OH; Lincoln Memorial University (DMN), Debusk College of Osteopathic Medicine, Knoxville, TN; Department of Pediatrics (DMC, ADP), The Ohio State University College of Medicine; and The Center for Clinical Excellence (ADP), Nationwide Children's Hospital, Columbus, OH
| | - Evelynne Wentzel
- Division of Emergency Medicine (CBL, DMN, DMC), Nationwide Children's Hospital; Pediatric Emergency Medicine (CBL), Abigail Wexner Research Institute at Nationwide Children's Hospital; The Ohio State University College of Medicine (BC); Division of Neurology (AD, NK, EW, ADP), Nationwide Children's Hospital; Endocrinology and Metabolism Institute (AD), Cleveland Clinic; Department of Pharmacy (JH), Nationwide Children's Hospital, Columbus, OH; Lincoln Memorial University (DMN), Debusk College of Osteopathic Medicine, Knoxville, TN; Department of Pediatrics (DMC, ADP), The Ohio State University College of Medicine; and The Center for Clinical Excellence (ADP), Nationwide Children's Hospital, Columbus, OH
| | - Daniel M Cohen
- Division of Emergency Medicine (CBL, DMN, DMC), Nationwide Children's Hospital; Pediatric Emergency Medicine (CBL), Abigail Wexner Research Institute at Nationwide Children's Hospital; The Ohio State University College of Medicine (BC); Division of Neurology (AD, NK, EW, ADP), Nationwide Children's Hospital; Endocrinology and Metabolism Institute (AD), Cleveland Clinic; Department of Pharmacy (JH), Nationwide Children's Hospital, Columbus, OH; Lincoln Memorial University (DMN), Debusk College of Osteopathic Medicine, Knoxville, TN; Department of Pediatrics (DMC, ADP), The Ohio State University College of Medicine; and The Center for Clinical Excellence (ADP), Nationwide Children's Hospital, Columbus, OH
| | - Anup D Patel
- Division of Emergency Medicine (CBL, DMN, DMC), Nationwide Children's Hospital; Pediatric Emergency Medicine (CBL), Abigail Wexner Research Institute at Nationwide Children's Hospital; The Ohio State University College of Medicine (BC); Division of Neurology (AD, NK, EW, ADP), Nationwide Children's Hospital; Endocrinology and Metabolism Institute (AD), Cleveland Clinic; Department of Pharmacy (JH), Nationwide Children's Hospital, Columbus, OH; Lincoln Memorial University (DMN), Debusk College of Osteopathic Medicine, Knoxville, TN; Department of Pediatrics (DMC, ADP), The Ohio State University College of Medicine; and The Center for Clinical Excellence (ADP), Nationwide Children's Hospital, Columbus, OH
| |
Collapse
|